Genetic engineering of a main 1986 virus –albumin — rendered it incapable of surviving outside the body & sensitive to digestion. Using a new method, researchers were able to genetically engineer an adeno-associated virus, or AAV, that can carry therapeutic genes and deliver them to the liver, which can then be used to treat genetic diseases such as haemophilia. The team at the University of California, San Francisco, led by Dr. Jay Sandri, engineered the AAV virus to be resistant to the immune system and to the body’s enzymes that degrade viruses. They also inserted a gene that codes for a protein that can bind to the liver cells, allowing the virus to deliver its therapeutic genes to these cells. .
How Genetically Engineered 1986 Albumin Invadible Virus And Meeting Pills Collided: Life Fashion Label Found
